Communicating for the Safe Use of Medicines: Progress and Directions for the 2020s Promoted by the Special Interest Group of the International Society of Pharmacovigilance

Priya Bahri (), Geoffrey Bowring, Brian D. Edwards, Christopher Anton, Jeffrey K. Aronson, Angela Caro-Rojas, Bruce P. J. Hugman, Peter G. Mol, Gianluca Trifirò, Katarina Ilic, Riadh Daghfous, Irene Fermont, Giovanni Furlan, Wolfgang Gaissmaier, Mohammad Ishaq Geer, Kenneth Y. Hartigan-Go, François Houÿez, Hansjörg Neth, Gediminas Norgela, Yaowares Oppamayun, D. K. Theo Raynor, Mehdi Bouhlel, Federica Santoro and Janet Sultana
Additional contact information
Priya Bahri: Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG)
Geoffrey Bowring: Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG)
Brian D. Edwards: Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG)
Christopher Anton: Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG)
Jeffrey K. Aronson: Nuffield Department of Primary Care Health Sciences
Angela Caro-Rojas: Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG)
Peter G. Mol: Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG)
Gianluca Trifirò: University of Verona
Katarina Ilic: Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG)
Riadh Daghfous: Tunisian National Centre of Pharmacovigilance
Irene Fermont: Israel Society for Medication and Vaccine Safety (ERANIM)
Giovanni Furlan: Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG)
Wolfgang Gaissmaier: University of Konstanz
Mohammad Ishaq Geer: University of Kashmir
Kenneth Y. Hartigan-Go: Special Interest Group on Medicinal Product Risk Communication of the International Society of Pharmacovigilance (ISoP CommSIG)
François Houÿez: European Organisation for Rare Diseases (EURORDIS)
Hansjörg Neth: University of Konstanz
Gediminas Norgela: Uppsala Monitoring Centre (UMC)
Yaowares Oppamayun: Thai Food and Drug Administration, Health Product Vigilance Center
D. K. Theo Raynor: University of Leeds
Mehdi Bouhlel: Tunisian National Centre of Pharmacovigilance
Federica Santoro: Uppsala Monitoring Centre (UMC)
Janet Sultana: Mater Dei Hospital

Drug Safety, 2023, vol. 46, issue 6, No 1, 517-532

Date: 2023
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40264-023-01285-5 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:drugsa:v:46:y:2023:i:6:d:10.1007_s40264-023-01285-5

Ordering information: This journal article can be ordered from
http://www.springer.com/adis/journal/40264

DOI: 10.1007/s40264-023-01285-5

Access Statistics for this article

Drug Safety is currently edited by Nitin Joshi

More articles in Drug Safety from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().